Integra Lifesciences EV/EBIT IART

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2011.

Today, Oct 23, 2026: 20.7×
10-year median: 37.7×
Against its 10-year history: 7th; percentile: 0 is its lowest day, 100 its highest
10-year range: 15.8× to 163×
Peer median: 24.7×

Integra Lifesciences' EV/EBIT is 20.7× as of Oct 23, 2026.

That is below its ten-year median of 37.7×, lower than on 93% of days in the last ten years.

Over that time it ranged from 15.8× in May 2023 to 163× in Oct 2025.

The median for 10 medical instruments and supplies stocks of a similar size is 24.7×.

EV/EBIT over time

median 37.7×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	20.7×	20.7×	75.0×
2025	47.4×	42.6×	163×
2024	54.6×	23.8×	59.2×
2023	27.3×	15.8×	27.8×
2022	21.7×	17.7×	32.4×
2021	31.6×	29.7×	45.2×
2020	42.6×	24.4×	43.5×
2019	37.7×	36.0×	58.1×
2018	48.4×	48.4×	120×
2017	54.4×	21.5×	57.0×
2016	22.1×	20.2×	40.4×
2015	28.2×	15.6×	28.5×
2014	15.7×	13.5×	33.9×
2013	32.7×	11.0×	32.7×
2012	14.4×	7.7×	19.2×
2011	10.0×	9.3×	14.3×

Against its peers

Companies in Medical - Instruments & Supplies nearest Integra Lifesciences' size, closest first, today.

Company	EV/EBIT
IARTIntegra Lifesciences	20.7×
IRMDIradimed	37.7×
STAAStaar Surgical	57.7×
MOVMovado	11.8×
BVSBioventus	26.2×
CDRECadre	23.2×
EYENational Vision	19.2×
MDXGMimedx	51.6×
TCMDTactile Systems Technology	13.3×
LMATLemaitre Vascular	22.6×
INSPInspire Medical Systems	32.6×
Peer median	24.7×

Where Integra Lifesciences ranks

#22of 46Medical instruments and supplies stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Integra Lifesciences

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.